Shanghai Fosun Pharma Declares Year-End Dividend
Company Announcements

Shanghai Fosun Pharma Declares Year-End Dividend

Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has declared a final dividend of RMB 0.27 per share for the fiscal year ended December 31, 2023, to be paid at an exchange rate of RMB 1 to HKD 1.09639, equivalent to HKD 0.3 per share. Shareholders must lodge transfer documents by July 29, 2024, to be entitled to the dividend, which will be paid on August 23, 2024. Non-resident individual and enterprise shareholders are subject to a 10% withholding tax, while Mainland investors through Stock Connect are subject to a 20% withholding tax.

For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma Announces New Drug Acceptance
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma’s New Drug Application Accepted
TipRanks HongKong Auto-Generated NewsdeskFosun Pharma Announces Corporate Governance Update
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!